| abstract |
the present invention relates to an artificially modified crispr / cas9 system. more particularly, the present invention relates to an artificially engineered crispr enzyme having improved target specificity and an use of an artificially modified crispr / cas9 system including the same enzyme in the manipulation or modification of the genome and / or epigenome, genome targeting, genome editing and in vitro diagnostics, etc. |